Erythrocyte sedimentation rate, rather than C-reactive protein, may be the preferred biomarker for hidradenitis suppurativa by Ruby S. Gibson, MD, Martina L. Porter, MD, Alexa B. Kimball, MD, MPH

Get full text

Placebo responders with moderate-to-severe hidradenitis suppurativa experience declines in inflammation as measured by C-reactive protein: a post hoc analysis of two double-blinded... by Simon J. Gunter, MPhil, Martina L. Porter, MD, Alexa B. Kimball, MD, MPH

Get full text

Prednisone and amoxicillin/clavulanic acid for the treatment of hidradenitis suppurativa flares: a prospective observational study by Ruby S. Gibson, MD, Corey L. Snyder, BSA, Martina L. Porter, MD, Alexa B. Kimball, MD, MPH

Get full text

Travel burden on patients at a subspecialty hidradenitis suppurativa clinic: a single-center retrospective study by Diana S. Kim, BA, Nicole Giannotti, BS, Prerna Salian, MPH, Alexa B. Kimball, MD, MPH, Martina L. Porter, MD

Get full text

Evaluating minority representation across health care settings in hidradenitis suppurativa and psoriasis by Charlotte Greif, MD, Ruby S. Gibson, MD, Alexa B. Kimball, MD, MPH, Zachary E. Holcomb, MD, Martina L. Porter, MD

Get full text

Data wobbles in hidradenitis suppurativa clinical trials and potential contributing factors: a retrospective review by Corey L. Snyder, MD, Ruby S. Gibson, MD, Stella X. Chen, MD, Martina L. Porter, MD, Alexa B. Kimball, MD, MPH

Get full text

Treatment of hidradenitis suppurativa resolves associated hematologic abnormalities by Peyton C. Morss-Walton, BA, Charlotte Greif, BA, Zachary E. Holcomb, MD, Prerna Salian, MPH, Tuyen Yankama, MPH, Diana Kim, BA, Martina L., Porter, MD, Alexa B. Kimball, MD, MPH

Get full text